Stonegate Updates Coverage on NCS Multistage Holdings, Inc. (NASDAQ: NCSM): 1Q26 Miss Highlights Timing Risks but Core Thesis Remains Intact

May 1st, 2026 1:40 PM
By: Newsworthy Staff

Stonegate Capital Partners maintains its positive outlook on NCS Multistage despite a first-quarter miss due to Canada and international timing, citing strong U.S. momentum, ResMetrics integration, and a back-half-weighted recovery.

Stonegate Updates Coverage on NCS Multistage Holdings, Inc. (NASDAQ: NCSM): 1Q26 Miss Highlights Timing Risks but Core Thesis Remains Intact

Stonegate Capital Partners has updated its coverage on NCS Multistage Holdings, Inc. (NASDAQ: NCSM) following the company's first-quarter 2026 results. While the quarter fell short of expectations, primarily due to timing issues in Canada and select international projects, robust U.S. revenue growth that more than doubled year-over-year helped offset the shortfall. According to Stonegate, the quarter does not alter the core investment thesis centered on U.S. product momentum, the integration of ResMetrics, and the company's capital-light business model. However, it does underscore the inherent timing risks associated with Canadian seasonality and project-based international work.

The key change is in the cadence of earnings, with second-quarter 2026 guidance indicating a softer near-term trough. Importantly, management maintained its full-year 2026 Adjusted EBITDA guidance, pointing to a recovery that is more heavily weighted toward the second half of the year. This anticipated recovery is tied to deferred Canadian work, recurring activity from the Repeat Precision product line, and synergies from the ResMetrics acquisition. Additionally, the company noted that its 2026 guidance excludes potential sliding sleeve deliveries for its first deepwater Gulf of Mexico opportunity, which could materialize in late 2026 or early 2027.

Stonegate highlighted several key takeaways from the quarter. First, the first-quarter miss was largely attributed to timing in Canada and international markets, but U.S. revenue more than doubled, preserving the overall thesis. Second, the maintained full-year EBITDA guidance shifts the focus to a second-half recovery and execution of the Repeat Precision strategy. Third, the company continues to generate positive free cash flow and boasts $53 million in liquidity, which supports the integration of ResMetrics, capacity expansion, and growth investments.

For more details, the full announcement is available at Stonegate Inc..

Source Statement

This news article relied primarily on a press release disributed by Reportable. You can read the source press release here,

blockchain registration record for the source press release.
;